Laboratory Corp. Of America Holdings LH

NYS: LH | ISIN: US50540R4092   8/07/2025
257,45 USD (-0,16%)
(-0,16%)   8/07/2025

8 mei 2025 · Labcorp to Webcast Its Annual Meeting of Shareholders May 15 · Persbericht

29 april 2025 · Labcorp Announces 2025 First Quarter Results · Persbericht

23 april 2025 · Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions · Persbericht

10 april 2025 · Labcorp Declares Quarterly Dividend · Persbericht

2 april 2025 · Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease · Persbericht

1 april 2025 · Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide · Persbericht

31 maart 2025 · Labcorp to Announce First Quarter Financial Results on April 29, 2025 · Persbericht

11 maart 2025 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

3 september 2024 · Labcorp to Speak at the Baird 2024 Global Healthcare Conference · Persbericht

5 augustus 2024 · Labcorp Finalizes Acquisition of Select Assets of Invitae · Persbericht

2 augustus 2024 · Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx · Persbericht

1 augustus 2024 · Labcorp Announces 2024 Second Quarter Results · Persbericht

30 juli 2024 · Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities · Persbericht

25 juli 2024 · Labcorp Declares Quarterly Dividend · Persbericht

1 juli 2024 · Labcorp to Announce Second Quarter Financial Results on August 1, 2024 · Persbericht

17 juni 2024 · Labcorp Launches Global Trial Connect to Accelerate Clinical Trials · Persbericht

3 juni 2024 · Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio · Persbericht

30 mei 2024 · Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting · Persbericht

28 mei 2024 · Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference · Persbericht

15 mei 2024 · Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy · Persbericht

Mijn selecties